28th June 2024
Why does cancer disproportionately affect LGBTQIA+ people? We spoke to Dr Alison Berner.
Read more27th May 2022
Dr Sarah McClelland from BCI is part of a collaborative project that has secured £1.2 million in funding from the Medical Research Council to investigate the mechanisms leading to cancer development in cells infected with human papillomavirus.
Read more4th February 2022
Vinaya Srirangam Nadhamuni, Clinical Research Fellow at Barts Cancer Institute, Queen Mary University of London, has been working on a project to make information about screening programmes more accessible to minority ethnic groups in the UK.
Read more3rd August 2021
Professor Jack Cuzick, Director of the Wolfson Institute of Preventive Medicine at Queen Mary University of London and Theme Lead for Cancer Prevention & Risk Reduction at the Cancer Research UK Barts Centre, has been awarded a Queen Mary Impact Award for his research on human papilloma virus (HPV) screening for cervical cancer, which has transformed cervical cancer prevention programmes worldwide.
Read more7th November 2019
Researchers from the Centre for Cancer Prevention have developed a non-invasive test to detect cervical pre-cancer by analysing urine and vaginal samples women collect themselves.
Read more12th June 2019
This week (10-16th June) is Cervical Screening Awareness Week, an initiative started by Jo’s Cervical Cancer Trust, which aims to raise awareness of the importance of cervical screening. In the UK, approximately 3,200 women are diagnosed with cervical cancer annually, making it the 14th most common cancer in women. Cervical screening, otherwise known as a smear test, can help to prevent cervical cancer, which claims 870 lives per year.
Read more